In 1995, Silberstein4 published the results of a telephone survey of 500 self-reported migraineurs. Almost all the survey respondents were women (443 women and 57 men), which is consistent with the greater prevalence of migraine in women than men. Most of the respondents (60%) had 3 or fewer migraine attacks per month; 15% reported 4 attacks per month, and 25% had 5 or more attacks per month. When describing their most recent migraine attack, 93% of patients reported moderate or severe headache pain, 76% had moderate or severe nausea, and 92% had moderate or severe visual problems. When asked to rate the importance of specific attributes of a migraine medication on a 10-point scale (with 1 indicating not at all important and 10, extremely important), survey respondents gave the highest ratings to "provides quick headache relief" (mean rating, 9.91) and "decreases headache pain" (mean rating, 9.87). Other migraine medication features considered important by the participants in this survey were "decreases likelihood of recurrence,"
"does not cause nausea," "decreases nausea," "decreases vomiting," "decreases sensitivity to light," "orally administered," "decreases visual problems," and "does not cause drowsiness."